Ocular Myasthenia Gravis clinical trials

Explore recruiting ocular myasthenia gravis clinical trials.

Recruiting ocular myasthenia gravis studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Ocular Myasthenia Gravis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Immediate corticosteroid therapy and rituximab to prevent generalization in ocular myasthenia gravis: a PROBE-type multicenter, open-label, randomized controlled trial

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Randomized, Double-Blinded, Placebo-Controlled, Phase 3, Parallel-Group Design Study Evaluating the Efficacy and Safety of Efgartigimod PH20 SC Administered by Prefilled Syringe in Adult Participants With Ocular Myasthenia Gravis

Spain, Cyprus, Netherlands, Czechia, Poland, Austria +9 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 1b/2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Investigate A) the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Ascending Doses of IM-101 in Adult Participants with Generalized Myasthenia Gravis, and B) the Efficacy and Safety of Treatment of IM-101 in Adult Participants with Generalized Myasthenia Gravis and Ocular Myasthenia Gravis

Bulgaria, Poland, Spain, Italy

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Ocular Myasthenia Gravis trials by city

Ocular Myasthenia Gravis in Toronto Ocular Myasthenia Gravis in Vancouver Ocular Myasthenia Gravis in Montreal Ocular Myasthenia Gravis in Calgary Ocular Myasthenia Gravis in Edmonton Ocular Myasthenia Gravis in Ottawa Ocular Myasthenia Gravis in Winnipeg Ocular Myasthenia Gravis in Quebec City Ocular Myasthenia Gravis in Hamilton Ocular Myasthenia Gravis in Kitchener Ocular Myasthenia Gravis in London Ocular Myasthenia Gravis in Halifax Ocular Myasthenia Gravis in New York Ocular Myasthenia Gravis in Los Angeles Ocular Myasthenia Gravis in Chicago Ocular Myasthenia Gravis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease